Daniel Abdun-Nabi, President & COO at Emergent BioSolutions Inc. (EBS), sold 178,515 shares at $24.91 ($4.4M) on 2011-05-31, disclosed to the SEC on 2011-06-02.
Open-market sale of $4.4M EBS by President & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.91 | 25,000 | $623K | 14.2% |
| 2 | $24.91 | 75,000 | $1.9M | 42.6% |
| 3 | $23.99 | 5,067 | $122K | 2.8% |
| 4 | $24.18 | 13,361 | $323K | 7.4% |
| 5 | $24.18 | 30,000 | $725K | 16.5% |
| 6 | $24.18 | 30,087 |
| $728K |
| 16.6% |
| Total | $24.58 avg | 178,515 | $4.4M | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |